News

As part of the agreement, Full Spectrum Genetics protein analysis and engineering platform, MapEng, and BioBlocks’ fragment based drug discovery platform technology,Fragment-to-Lead, will be combined. The technologies will

The research will focus on data originating from biotechnology companies,academia and from internal research projects. The studies will be carried out from Type 1 Diabetes R&D Center of

In collaboration with Bayer HealthCare, Genzyme is developing lemtrada in MS. Genzyme President and CEO David Meeker said, "There remains a large unmet treatment need for patients living

The all-cash transaction is expected to expand Amgen’s presence in Turkey and the surrounding region. The acquisition was initially announced on 25 April 2012. MN Pharmaceuticals, a manufacturer

A vegetarian and sustainable source was used in DHA, a polyunsaturated omega-3 fatty acid found throughout the body, in the human studies. The DHA is a major structural

The agreement will focus on developing the manufacturing platform for PTH-CBD, that will allow BiologicsMD to conduct Phase I studies. BiologicsMD president Paul Mlakar said Cytovance expertise will

The collaboration will leverage BioInvent’s F.I.R.S.T. technology, a functional approach to therapeutic antibody discovery. The research team will provide the collaboration with biological pathways for the development of

Pierre Fabre, as contract manufacturer, will produce the active ingredient in ANX-188 for use in clinical trials, including the Phase 3 study of ANX-188 that ADVENTRX plans to

Toctino is used to treat adults with severe chronic hand eczema that is refractory to treatment with potent topical corticosteroids. Under the agreement Stiefel will be responsible for